Glaxosmithkline Pharmaceuticals Ltd (GLAXO)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 2820.00
% Change: 0.64% (Prev Close: 2802.20)

Volume: 55,776
% Change: -19.53% (Prev Volume: 69,313)

Delivery: 36,144
Delivery % : 64.80
% Change: -8.98% (Prev Delivery: 39,711)

Turnover: 1,566 Lacs
% Change: -19.32% (Prev Turnover: 1,940)

πŸ’Ή EOD Valuation

P/E Ratio: 50.28
P/B Ratio: 24.48
Market Cap: 47771 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: GLAXO
Market Cap: 47180 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 3515.95
52 Week Low: 1921.00

All-Time High: 3515.95 Rs.
All-Time Low: 346.05 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-1.83% | -19.24% | 0.92% | -2.53% | 24.47%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 75.00%

Change (3Y | 1Y): 0.00% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 4.89%

Change (3Y | 1Y): 2.73% | 0.37%

DII Holding

DII Holding: 7.71%

Change (3Y | 1Y): -2.94% | -0.08%

Public Holding: 12.41%

🏦 Financial Strength

Debt to Equity: 0.01
Debt: 9.95 Rs. Cr.

Book Value: 115.19 Rs.
Current Ratio: 1.20
Interest Coverage: 945.68
Free Cash Flow: 1272.60 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 6.65%

Sales Growth Qtr (YOY | QoQ):
-1.16% | -17.37%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
3.06% | 4.58% | 6.65%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 22.94%

Profit Growth Qtr (YOY | QoQ):
12.44% | -22.01%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
34.71% | -19.63% | 22.94%

EPS Rs.

EPS (TTM): 56.09 Rs.

EPS Qtr (Last Year | Latest):
10.76 Rs. | 12.10 Rs.

EPS Annual (Last Annual | Annual March):
34.83 Rs. | 54.75 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
34.71% | -19.63%

Net Profit Rs. Cr.

Net Profit (TTM): 950.26 Rs. Cr.

Net Profit (Annual - March): 927.58 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
182.33| 262.87 | 205.01

EBITDA Rs. Cr.

EBITDA (Quarter): 294.92 Rs. Cr.
EBITDA (Previous Yr Ql): 266.18 Rs. Cr.

EBITDA (Annual - March): 1255.15 Rs. Cr.
EBITDA (Previous Annual): 981.62 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
11.33% | 14.47%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 32.03%

OPM Qtr (Previous | Current):
34.20% | 31.20%

OPM Annual (5 Yrs | Last Yr | March):
25.52% | 26.31% | 31.44%

Return on Equity %

ROE: 46.87%

ROE (5 Yrs | 3 Yrs | Last Yr):
44.83% | 36.39% | 37.32%

Return on Capital Employed %

ROCE: 63.25%

ROCE (5 Yrs | 3 Yrs | Last Yr):
45.09% | 50.33% | 51.33%

Return on Assets %

ROA (TTM): 22.80%

ROA (5 Yrs | 3 Yrs | Last Yr):
23.08% | 18.90% | 19.08%

PEG Ratio: -2.54
Dividend Yield: 1.51%

PE 3 Yrs: 53.00
PE 5 Yrs: 56.12

Dividend Yield: 1.51%

πŸ‘₯ Company

Glaxosmithkline Pharmaceuticals Ltd

GLAXO

Promoter Holding: %